AKTX Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 22:00):

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases...

Stats
Dagens volum	22 004.00
Gjennomsnittsvolum	11 858.00
Markedsverdi	7.84M
EPS	$2.00 ( 2023-10-03 )
Neste inntjeningsdato	( $0 ) 2024-05-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.630
ATR14	$0.0270 (2.11%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-01	Jacques Rachelle Suzanne	Sell	0	Ordinary Shares, par value $0.0001 per share
2024-01-01	Jacques Rachelle Suzanne	Sell	29 762 300	Stock Option (Right to Buy)
2023-06-01	Jacques Rachelle Suzanne	Sell	152 690 700	Stock Option (Right to Buy)
2024-07-17	Dicicco Wendy F	Sell	5 000 000	Stock Option (Right to Buy)
2024-01-01	Patel Samir Rashmikant	Buy	0	Ordinary Shares, par value $0.0001 per share

INSIDER POWER
-100.00
Last 82 transactions
Buy: 68 941 813 \| Sell: 428 362 177

Akari Therapeutics PLC Korrelasjon

10 Mest positive korrelasjoner
SWVL	0.972
NAKD	0.968
SNGX	0.964
GROM	0.963
DIBS	0.963
AVIR	0.962
CSSE	0.962
JAGX	0.962
PSTX	0.961
RUBY	0.96

10 Mest negative korrelasjoner
AGZD	-0.97
DXJS	-0.965
TIGO	-0.958
PRAA	-0.954
PDFS	-0.95
GPACU	-0.948
MEOH	-0.947
UNAM	-0.945
SLMBP	-0.945
PANL	-0.944

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Akari Therapeutics PLC Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-4 000.00 (0.00 %)
EPS:	$-2.04

FY	2023
Omsetning:	$0
Bruttogevinst:	$-4 000.00 (0.00 %)
EPS:	$-2.04

FY	2022
Omsetning:	$0
Bruttogevinst:	$-3 708.00 (0.00 %)
EPS:	$-2.23

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-0.406

Financial Reports:

No articles found.

Akari Therapeutics PLC

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid. Akari Therapeutics, Plc is based in London, the United Kingdom.